Abstract | OBJECTIVES: DESIGN: Prospective, randomised, double-blinded, placebo controlled trial. METHODS: RESULTS: No adverse effects of the superficial cervical plexus block were reported. Four patients in the placebo group were excluded because of other drug use post-operatively. Per protocol analysis compared 23 patients in ropivacaine group and 19 patients in the placebo group. The ropivacaine group had a significant reduction in morphine consumption (3.8+/-2.0 versus 12.9+/-4.0, p<0.001), lower maximal pain scores (2.6+/-2.0 versus 5.8+/-1.6, p<0.001), and paCO2 levels (39.0+/-2.6 versus 41.9+/-3.4, p=0.008) at discharge from the recovery room. Patient satisfaction (1=very good to 6=insufficient) was substantially higher in the ropivacaine group (1.7+/-0.7 versus 3.1+/-1.2, p<00.01). CONCLUSION:
|
Authors | M Messner, S Albrecht, W Lang, R Sittl, M Dinkel |
Journal | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
(Eur J Vasc Endovasc Surg)
Vol. 33
Issue 1
Pg. 50-4
(Jan 2007)
ISSN: 1078-5884 [Print] England |
PMID | 16962799
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Amides
- Analgesics, Opioid
- Anesthetics, Local
- Carbon Dioxide
- Morphine
- Ropivacaine
|
Topics |
- Aged
- Aged, 80 and over
- Amides
(administration & dosage)
- Analgesia, Patient-Controlled
- Analgesics, Opioid
(therapeutic use)
- Anesthetics, Local
(administration & dosage)
- Carbon Dioxide
(blood)
- Carotid Artery Diseases
(blood, surgery)
- Cervical Plexus
- Double-Blind Method
- Endarterectomy, Carotid
(methods)
- Female
- Humans
- Male
- Middle Aged
- Morphine
(therapeutic use)
- Nerve Block
- Pain Measurement
- Pain, Postoperative
(prevention & control)
- Patient Satisfaction
- Prospective Studies
- Ropivacaine
- Time Factors
- Treatment Outcome
|